Richard Pascoe
Chairman
Zevra Therapeutics, Inc. (ZVRA)Equibles does not estimate personal net worth.
Get an email with a short summary when Zevra Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ZVRA alertsAbout Richard Pascoe
Richard Pascoe is recorded as Chairman at Zevra Therapeutics, Inc. (ZVRA). The proxy statement of Zevra Therapeutics, Inc. reports total compensation of $4,122,558 for Richard Pascoe in fiscal 2023, including a base salary of $273,576. Disclosed compensation is on record for 3 fiscal years. Zevra Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Zevra Therapeutics, Inc. includes Christal M.M. Mickle (CEO), Neil F. McFarlane (CEO and Board Member), Richard W. Pascoe (CEO) and 7 others.
Affiliation history
-
Current
-
Start not stated–2023-06-01
Company network
Leadership on record at Zevra Therapeutics, Inc.
- Christal M.M. Mickle CEO
- Neil F. McFarlane CEO, Board Member
- Richard W. Pascoe CEO
- Matthew R. Plooster Chairman
- Tamara A. Favorito Chairman
- Timothy Sangiovanni CFO
- Alicia Secor Board Member
- Alvin Shih, M.D. Board Member
- Christopher A. Posner Board Member
- Corey Watton Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Zevra Therapeutics, Inc. (ZVRA) | CEO | $273,576 | $4,122,558 |
| 2022 | Zevra Therapeutics, Inc. (ZVRA) | CEO | $422,917 | $1,360,976 |
| 2021 | Zevra Therapeutics, Inc. (ZVRA) | Chairman | $119,814 | $712,482 |
Recent activity
No call appearances or filed executive changes recorded yet.